SciELO - Scientific Electronic Library Online

 
vol.16 issue1Behaviour of the uric acid in the general casuistic and in patients with peripheral vascular diseaseImportance of the interpretation of the total cholesterol and triglyceride content for the diagnosis of dyslipidemias author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Angiología y Cirugía Vascular

On-line version ISSN 1682-0037

Abstract

PANTALEON BERNAL, Olga Silvia; TRIANA MANTILLA, María Eugenia; ALDAMA FIGUEROA, Alfredo  and  VALDES NARANJO, Yanelli. Control of the oral anticoagulant treatment in the older population with thromboembolic venous disease. Rev Cubana Angiol Cir Vasc [online]. 2015, vol.16, n.1, pp. 44-53. ISSN 1682-0037.

Introduction: the scope of the oral anticoagulant treatment indications and the older age of patients in need of this treatment favored changes in its use and control without reducing its efficacy, so this is considered beneficial therapeutics for the elderly. Objective: to describe the behavior of the control of oral anticoagulant treatment in the elderly population with thromboembolic venous disease. Methods: a descriptive and analytical study of 76 patients (60 to 85 years) seen at the specialized service of the National Institute of Angiology and Vascular Surgery in two years. The level of control of anticoagulation was evaluated, the frequency of hemorrhagic events and other complications were determined. Results: good control of the oral anticoagulant treatment was reached during the 2 year-period in younger than and over 60 years-old patients. No significant statistical difference was found when comparing the two groups. A higher index of slight hemorrhagic events was found in the study sample Conclusions: the control of the oral anticoagulant treatment in the older adult behaved similarly to that of the patient younger than 60 years, so the above mentioned treatment should be used in all the indications if the risk-benefit ratio is considered.

Keywords : oral anticoagulation; older patients; thromboembolic venous disease; therapeutic control.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )